- Global Pharma News & Resources

Fructosamine Test Market | Global Opportunities and Forecast Analysis 2022-2028

Fructosamine testing is used to monitor a person’s blood glucose level if they have diabetes mellitus. It is also useful in determining the efficacy of changes in one’s diabetic treatment plan, such as dietary, exercise, or medication changes.

For more insights into the market, request a sample of this report@

When glucose combines with protein, specifically albumin, the compound fructosamine is formed, and this glycated protein is measured using the frustosamine test. The amount of glycated protein in the blood is proportional to the amount of glucose present. These combined molecules exist until the protein or RBC are no longer present in the blood.

The Fructosamine test is more effective than the HbA1c test in that it aids in diabetes management by providing information on a person’s average blood glucose levels over the previous 14-21 days. This test is not commonly used and is only recommended by a practitioner when monitoring a person’s average glucose levels over the previous 2 to 3 weeks.

Fasting is also not required for the test. In situations where A1c cannot be reliably measured, the American Diabetes Association (ADA) wants to consider the fructosamine test as a substitute.

Since the early 1980s, laboratories have been offering fructosamine tests. A Fructosamine test is useful for patients suffering from Hemolytic Anemia, which can impair the accuracy of a Hemoglobin A1C test. Fructosamine levels in the blood have also been found to be an independent predictor of vascular outcomes. A recent study confirms the link between chronically elevated fructosamine and prevalent retinopathy.

Fructosamine Test Market: Drivers & Restraints

The rising diabetic population, increased diabetes care, increased access to diagnostic facilities, and patient awareness are all driving factors in the fructosamine test market.

Some of the factors limiting the fructosamine test market include a lack of standardisation as well as concerns about the test’s reproducibility. The Fructosamine test is also not recommended for routine use or as a substitute for A1C, limiting its market growth.

Several studies have found a strong link between a chronically elevated HbA1c level and the development of diabetes, which limits the use of the fructosamine test.

Fructosamine Test Market: Overview

Market participants must concentrate on introducing new innovations and making their products adorable. Because the test has been available in the field of clinical diagnosis for a long time, any significant growth rate cannot be anticipated unless new products are launched and significant improvements are made.

Market participants can increase their market share by branding their products and improving their network with various end users. Several studies have also found that serum fructosamine increases the risk of cardiovascular disease morbidity and mortality.

For Information On The Research Approach Used In The Report, Ask Analyst @ 

The test is being used for several research purposes in clinical trials for the development of novel medications for diabetes.

Fructosamine Test Market: Region-wise Outlook

Geographically, North America leads the Fructosamine Test market due to increased demand for these projects, increased population awareness, and easy access to healthcare facilities. Furthermore, the region’s growing diabetic population will drive the Fructosamine Test market.

Because of favourable government support and a greater emphasis on personal health, the North American market is followed by the Western European market. Japan is an established market for Fructosamine Test services as well.

This is followed by the Asia-Pacific market, which has increased access to diagnostic facilities and a growing healthcare services market. During the forecast period, Latin America will have the lowest market share and growth rate, followed by the Middle East and Africa.

Fructosamine Test Market: Key Players

Some of the service providers in the fructosamine test market include Idexx, Randox Laboratories Ltd., Abbexa Ltd,Biorbyt Ltd., Bioo Scientific Corporation, BioVision Inc., Eurolyser Diagnostica GmbH, Henry Schein, Inc. and others.

The research report provides an in-depth analysis of the market and includes thoughtful insights, facts, historical data, and statistically supported and industry-validated market data.

It also includes projections based on an appropriate set of assumptions and methodologies. The research report analyses and provides information based on market segments such as geography, application, and industry.

The report is a compilation of first-hand information, qualitative and quantitative analysis by industry analysts, and input from industry experts and value chain participants.

The report examines parent market trends, macroeconomic indicators, and governing factors, as well as market attractiveness by segment. The qualitative impact of various market factors on market segments and geographies is also depicted in the report.

Fructosamine Test Market: Segmentation

Segmentation by Product Type

  • Human Use Kits
  • Veterinary Use Kits
  • Research Use Kits

Segmentation by Service Type

  • Laboratory Testing
  • Point-of-Care Testing

Segmentation by End User

  • Hospitals
  • Clinics
  • Diagnostic Laboratories

Buy Now Complete Research Report@

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.


Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries:
Browse All Reports:

Editor Details

Last Updated: 08-Nov-2022